Production (Stage)
Apyx Medical Corporation
APYX
$1.54
-$0.12-7.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 45.22% | 51.83% | -1.60% | -559.56% | -117.51% |
| Total Depreciation and Amortization | -12.10% | -6.58% | -22.58% | 3.31% | -22.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -48.53% | -61.06% | -19.92% | 296.98% | 12.07% |
| Change in Net Operating Assets | 923.17% | -117.49% | -119.17% | 121.13% | -301.92% |
| Cash from Operations | 88.93% | -32.78% | -220.13% | 10.78% | -237.11% |
| Capital Expenditure | -57.14% | -163.44% | 12.07% | -85.26% | 68.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -57.14% | -163.44% | 12.07% | -104.06% | 68.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 99.95% | 61.54% | 50.00% | 44.44% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -133.86% | -- | -- | -- |
| Cash from Financing | 600.00% | -71.65% | -103.05% | -110.87% | -100.06% |
| Foreign Exchange rate Adjustments | -81.82% | 814.29% | -116.13% | 123.46% | 118.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.54% | -82.67% | -227.63% | -307.01% | -205.06% |